Bausch & Lomb (NYSE: BLCO) grants 15,842 RSUs to director

Rhea-AI Filing Summary

Bausch & Lomb Corporation director Ross Thomas W. Sr. reported an acquisition of 15,842 common shares tied to a new equity award. The filing shows this as a grant of restricted share units (RSUs) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated.

The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders and will be settled in common shares. After this grant, Ross directly holds 85,233 common shares, indicating this is a routine annual equity award for a non-employee director rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ross Thomas W. Sr.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 85,233 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 15,842 shares Grant reference price: $15.78 per share Shares owned after grant: 85,233 shares

3 metrics

RSUs granted 15,842 shares Annual grant to non-employee director

Grant reference price $15.78 per share Reported price for RSU grant

Shares owned after grant 85,233 shares Direct holdings following transaction

Key Terms

restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, annual meeting of shareholders

3 terms

restricted share units ("RSUs") financial

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

annual meeting of shareholders financial

"scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ross Thomas W. Sr.

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN L4K 4B4

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/26/2026		A		15,842(1)	A	$15.78	85,233	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Bausch & Lomb (BLCO) disclose for director Ross Thomas W. Sr.?

Bausch & Lomb disclosed that director Ross Thomas W. Sr. received 15,842 restricted share units as an annual equity award. These RSUs convert into common shares upon vesting, increasing his direct holdings to 85,233 shares following the transaction.

Is the BLCO Form 4 for Ross Thomas W. Sr. a stock purchase or a compensation grant?

The BLCO Form 4 reflects a compensation grant, not an open-market stock purchase. It records an annual award of 15,842 restricted share units to a non-employee director under the company’s 2022 Omnibus Incentive Plan, to be settled in common shares after vesting.

When do the restricted share units granted to Bausch & Lomb director Ross Thomas W. Sr. vest?

The restricted share units granted to Ross Thomas W. Sr. are scheduled to vest immediately before the conclusion of Bausch & Lomb’s next annual meeting of shareholders. Once vested, they will be settled in common shares, increasing his share ownership at that time.

How many Bausch & Lomb shares does Ross Thomas W. Sr. hold after the latest RSU grant?

After the latest grant, Ross Thomas W. Sr. holds 85,233 common shares of Bausch & Lomb directly. This total includes the impact of the 15,842-share restricted stock unit award reported in the Form 4 insider transaction filing for the non-employee director.

What plan governs the RSU grant reported in Bausch & Lomb’s Form 4 for Ross Thomas W. Sr.?

The RSU grant is made under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. This plan authorizes equity-based compensation, including restricted share units for non-employee directors, which are settled in common shares after they vest.